Author

William L. Dahut

National Institutes of HealthORCID 0000-0002-2766-9703Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alejandro A. SchäfferiD· 2 shared Eytan RuppiniD· 2 shared Aakanksha VermaiD· 1 shared Adam G. SowalskyiD· 1 shared Alessandro GennaiD· 1 shared Andrea Borghese ApoloiD· 1 shared Andrew E. GreensteiniD· 1 shared Anson T. KuiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Alejandro A. SchäfferORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJan 17, 2025

TMPRSS2-ERG confers resistance to antiandrogens: mechanism and therapeutic implications

Arunachalam Sekar, Rishita Chatterjee, Boobash Raj Selvadurai…·Yosef Yarden

This study shows that TMPRSS2-ERG fusion promotes resistance to antiandrogens by interacting with GR, suggesting combined GR and AR inhibition could benefit tERG-positive prostate cancer patients.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsMedPeer-reviewedDec 12, 2022

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome

Gal Dinstag, Eldad David Shulman, Efrat Elis…·Ranit Aharonov

ENLIGHT predicts patient response to targeted and immunotherapies using tumor transcriptomes without prior treatment response data, showing better accuracy than existing transcriptomics-based signatures.

49 citations

humanbulk RNA-seq

𝕏 PostBluesky